Gitelman’s syndrome and pregnancy: new potential pathophysiological influencing factors, therapeutic approach and materno-fetal outcome

References

• Gitelman HJ, Graham JB, Welt LG. A new familial disorder characterized by hypokalemia and hypomagnesemia. Trans Assoc Am Physicians 1966;79:221–235.
   PubMedGoogle Scholar
• Warnock DG. Renal genetic disorders related to K+ and Mg2+. Annu Rev Physiol 2002;64:845–876.
   PubMed Web of Science ®Google Scholar
• Naesens M, Steels P, Verberckmoes R, Vanrenterghem Y, Kuypers D. Bartter’s and Gitelman’s syndromes: From gene to clinic. Nephron Physiol 2004;96:p65–p78.
   PubMedGoogle Scholar
• Mascetti L, Bettinelli A, Simonetti GD, Tagliabue A, Syrén ML, Nordio F, Bianchetti MG. Pregnancy in inherited hypokalemic salt-losing renal tubular disorder. Obstet Gynecol 2011;117:512–516.
   PubMed Web of Science ®Google Scholar
• Morton A, Panitz B, Bush A. Eplerenone for gitelman syndrome in pregnancy. Nephrology (Carlton) 2011;16:349.
   PubMed Web of Science ®Google Scholar
• Calò LA, Pessina AC, Semplicini A. Angiotensin II signaling in the Bartter’s and Gitelman’ssyndromes, a negative human model of hypertension. High Blood Press Cardiovasc Prev 2005;12:17–26.
   Google Scholar
• Calò LA. Vascular tone control in humans: Insights from studies in Bartter’s/Gitelman’s syndromes. Kidney Int 2006;69:963–966.
   PubMed Web of Science ®Google Scholar
• Calò LA, Pessina AC. RhoA/Rho-kinase pathway: Much more than just a modulation of vascular tone. Evidence from studies in humans. J Hypertens 2007;25:259–264.
   PubMed Web of Science ®Google Scholar
• Bettinelli A, Tosetto C, Colussi G, Tommasini G, Edefonti A, Bianchetti MG. Electrocardiogram with prolonged QT interval in Gitelman disease. Kidney Int 2002;62:580–584.
   PubMed Web of Science ®Google Scholar
• Calò L, Scognamiglio R, Nistri S, Palisi M, Miorelli M, Zerbo F, Cantaro S, et al. Evidence of myocardial dysfunction in Bartter’s syndrome. Am J Nephrol 1997;17:124–127.
   PubMed Web of Science ®Google Scholar
• Scognamiglio R, Negut C, Calò LA. Aborted sudden cardiac death in two patients with Bartter’s/Gitelman’s syndromes. Clin Nephrol 2007;67:193–197.
   PubMed Web of Science ®Google Scholar
• Scognamiglio R, Calò LA, Negut C, Coccato M, Mormino P, Pessina AC. Myocardial perfusion defects in Bartter and Gitelman syndromes. Eur J Clin Invest 2008;38:888–895.
   PubMed Web of Science ®Google Scholar
• Jones JM, Dorrell S. Outcome of Two Pregnancies in a Patient with Gitelman’s syndrome-A Case Report. J Matern-Fetal Investig 1998;8:147–148.
   PubMedGoogle Scholar
• Basu A, Dillon RD, Taylor R, Davison JM, Marshall SM. Is normalisation of serum potassium and magnesium always necessary in Gitelman syndrome for a successful obstetric outcome? BJOG 2004;111:630–634.
   PubMed Web of Science ®Google Scholar
• Talaulikar GS, Falk MC. Outcome of pregnancy in a patient with Gitelman syndrome: A case report. Nephron Physiol 2005;101:p35–p38.
   PubMedGoogle Scholar
• de Haan J, Geers T, Berghout A. Gitelman syndrome in pregnancy. Int J Gynaecol Obstet 2008;103:69–71.
   PubMed Web of Science ®Google Scholar
• de Arriba G, Sánchez-Heras M, Basterrechea MA. Gitelman syndrome during pregnancy: A therapeutic challenge. Arch Gynecol Obstet 2009;280:807–809.
   PubMed Web of Science ®Google Scholar
• McCarthy FP, Magee CN, Plant WD, Kenny LC. Gitelman’s syndrome in pregnancy: Case report and review of the literature. Nephrol Dial Transplant 2010;25:1338–1340.
   PubMed Web of Science ®Google Scholar
• Daskalakis G, Marinopoulos S, Mousiolis A, Mesogitis S, Papantoniou N, Antsaklis A. Gitelman syndrome-associated severe hypokalemia and hypomagnesemia: Case report and review of the literature. J Matern Fetal Neonatal Med 2010;23:1301–1304.
   PubMed Web of Science ®Google Scholar
• Kwan TK, Falk MC. Second pregnancy outcome in a patient with Gitelman syndrome without the use of parenteral electrolyte supplementation. Aust N Z J Obstet Gynaecol 2011;51:94–95.
   PubMed Web of Science ®Google Scholar
• Calò L, Davis PA, Milani M, Cantaro S, Antonello A, Favaro S, D’Angelo A. Increased endothelial nitric oxide synthase mRNA level in Bartter’s and Gitelman’s syndrome. Relationship to vascular reactivity. Clin Nephrol 1999;51:12–17.
   PubMed Web of Science ®Google Scholar
• Caló L, D’Angelo A, Cantaro S, Bordin MC, Favaro S, Antonello A, Borsatti A. Increased urinary NO2-/NO3- and cyclic guanosine monophosphate levels in patients with Bartter’s syndrome: Relationship to vascular reactivity. Am J Kidney Dis 1996;27:784–789.
   PubMed Web of Science ®Google Scholar
• Calò LA, Schiavo S, Davis PA, Pagnin E, Mormino P, D’Angelo A, Pessina AC. ACE2 and angiotensin 1-7 are increased in a human model of cardiovascular hyporeactivity: Pathophysiological implications. J Nephrol 2010;23:472–477.
   PubMed Web of Science ®Google Scholar
• De Mello WC. Opposite effects of angiotensin II and angiotensin (1-7) on impulse propagation, excitability and cardiac arrhythmias. Is the overexpression of ACE2 arrhythmogenic? Regul Pept 2009;153:7–10.
   PubMedGoogle Scholar
• Cox JL, Gardner MJ. Treatment of cardiac arrhythmias during pregnancy. Prog Cardiovasc Dis 1993;36:137–178.
   PubMed Web of Science ®Google Scholar
• McAnulty JH, Morton MJ, Ueland K. The heart and pregnancy. Curr Probl Cardiol 1988;13:589–665.
   PubMed Web of Science ®Google Scholar